QR Pharma, Inc. announced the election of Mr. Michael Hoffman as Chairman of the Board of Directors and Mr. Dhesh Govender as Director. Mr. M. B. Hoffman is a Partner of Riverstone Holdings LLC. Dhesh S.K. Govender is currently CEO and Founder of Tara Immuno-Oncology LLC.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.29 USD | +2.97% | -12.27% | -61.02% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.02% | 81.44M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- ANVS Stock
- News Annovis Bio, Inc.
- QR Pharma, Inc. Appoints Management